Nasdaq flags GoHealth noncompliance with $35 million MVLS listing rule

Reuters03-21
Nasdaq flags <a href="https://laohu8.com/S/GOCO">GoHealth</a> noncompliance with $35 million MVLS listing rule
  • GoHealth received a Nasdaq notice that it is not in compliance with Listing Rule 5550(b)(2), which requires a minimum market value of listed securities of 35.0 million.
  • The notice also said the company does not meet alternative continued listing standards under Rules 5550(b)(1) and 5550(b)(3), including stockholders’ equity of at least 2.5 million or net income from continuing operations of 500,000.
  • Nasdaq set a 180-day compliance period ending September 14, 2026, for GoHealth to regain compliance with the market value requirement.
  • Failure to regain compliance during the period could result in a delisting determination, which the company may appeal to a Nasdaq Hearings Panel.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoHealth Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-020176), on March 20, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment